SIM
ASXC

Studio Investment Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Studio Investment Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-49
Closed -$16 – 325
2024
Q2 		$16 Hold
49
– – ﹤0.01% 299
2024
Q1 		$11 Hold
49
– – ﹤0.01% 266
2023
Q4 		$16 Hold
49
– – ﹤0.01% 242
2023
Q3 		$13 Hold
49
– – ﹤0.01% 232
2023
Q2 		$25 Hold
49
– – ﹤0.01% 221
2023
Q1 		$32 Hold
49
– – ﹤0.01% 222
2022
Q4 		$17 Hold
49
– – ﹤0.01% 199
2022
Q3 		$22 Hold
49
– – ﹤0.01% 167
2022
Q2 		$0 Buy
+49
New +$22 ﹤0.01% 194

Other funds holding ASXC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Studio Investment Management's ASXC Position: Q3 2024 in Review

Studio Investment Management sold out of Asensus Surgical, Inc. (ASXC) in Q3 2024, closing a stake of 49 shares — an estimated $16 sold.

Studio Investment Management first reported a position in ASXC in Q2 2022 and held it in 9 quarters. The position peaked at $32 in Q1 2023. 1 fund tracked by Wall St. Rank holds ASXC as of Q3 2024.

  • Studio Investment Management reported no remaining Asensus Surgical, Inc. position as of Q3 2024 after selling out during the quarter.
  • Studio Investment Management sold 49 Asensus Surgical, Inc. shares in Q3 2024, an estimated $16.
  • Studio Investment Management first reported a position in Asensus Surgical, Inc. in Q2 2022 and held it in 9 quarters.
  • Studio Investment Management's Asensus Surgical, Inc. position peaked at $32 in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2024.

Based on Studio Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.